Evaluation of bipolar Transurethral Enucleation and Resection of the Prostate in terms of efficiency and patient satisfaction compared to retropubic open prostatectomy in prostates larger than 80 cc. A prospective randomized study

Submitted: August 1, 2023
Accepted: August 31, 2023
Published: November 21, 2023
Abstract Views: 606
PDF: 365
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Objectives: To compare the outcomes of bipolar Transurethral Enucleation Resection of the Prostate (TUERP) and simple retropubic prostatectomy in patients with prostate volumes larger than 80 cc. Patients and methods: A prospective randomized study included all patients amenable to surgeries for benign prostate hyperplasia (BPH) with prostate size over 80 cc at a tertiary care hospital between January 2020 to February 2022. Bipolar TUERP and Retropubic open prostatectomy techniques were compared regarding patients' demographics, intraoperative parameters, outcomes, and peri-operative complications. Results: Ninety patients were included in our study and randomly assigned to bipolar TUERP (Group 1 = 45 patients) and retropubic open prostatectomy (Group 2 = 45 patients). The TUERP group demonstrated significantly lower operative time (77 ± 11 minutes vs. 99 ± 14 minutes, p < 0.001), hemoglobin drop (median = 1.1 vs. 2.5, p < 0.001), and resected tissue weight (71 ± 6.6 cc vs. 84.5 ± 10.6 cc, p < 0.001). Postoperatively, the TUERP group demonstrated significantly lower catheter time (median = 2 vs. 7 days, p < 0.001) and less hospital stay. IPSS, Qmax, and patient satisfaction were better in the TUERP group within six months of surgery. We reported 90-day complications after TUERP in 13.3% of patients compared to 17.8% after retropubic prostatectomy, with a statistically insignificant difference. Urethral stricture predominated after TUERP, while blood transfusion dominated in retropubic prostatectomy. Conclusions: The present study found that TUERP had equivalent efficacy and safety to open retropubic prostatectomy for patients with BPH and prostate volumes > 80 ml.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Gravas, SCJN, Cornu JN, Gacci M, et al. Management of nonneurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Association of Urology, 2019. (European Association of Urology. Guidelines).
Rao JM, Yang JR, Ren YX, et al. Plasmakinetic enucleation of the prostate versus transvesical open prostatectomy for benign prostatic hyperplasia > 80 mL: 12-month follow-up results of a randomized clinical trial. Urology. 2013; 82:176-81. DOI: https://doi.org/10.1016/j.urology.2013.02.032
Chen S, Zhu L, Cai J, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with longterm results at 6 years. Eur Urol. 2014; 66:284-291. DOI: https://doi.org/10.1016/j.eururo.2014.01.010
Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol. 2007; 52:1465-1472. DOI: https://doi.org/10.1016/j.eururo.2007.04.074
Lourenco T, Armstrong N, N’dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess. 2008; 12: 1-146. DOI: https://doi.org/10.3310/hta12350
Millin T. The surgery of prostatic obstructions. Irish Journal of Medical Science (1926-1967). 1947; 22:185-189. DOI: https://doi.org/10.1007/BF02937798
Miernik A, Gratzke C. Current treatment for benign prostatic hyperplasia. Deutsches Ärzteblatt International. 2020; 117:843. DOI: https://doi.org/10.3238/arztebl.2020.0843
Hwang EC, Jung JH, Borofsky M, et al. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2019; 2. DOI: https://doi.org/10.1002/14651858.CD013143.pub2
Wei Y, Xu N, Chen SH, et al. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: a retrospective study at a single academic tertiary care center. International Braz J Urol. 2016; 42:747-756. DOI: https://doi.org/10.1590/S1677-5538.IBJU.2015.0225
Ou R, Deng X, Yang W, et al. Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes > 80 mL: a prospective randomized study. BJU international. 2013; 112:239-245. DOI: https://doi.org/10.1111/bju.12181
Geavlete B, Bulai C, Ene C, et al. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases. J Endourol. 2015; 29:323-331. DOI: https://doi.org/10.1089/end.2014.0493
Xu P, Xu A, Chen B, et al. Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP? Asian J Urol. 2018; 5:48-54. DOI: https://doi.org/10.1016/j.ajur.2017.12.001
Wang Y, Wang X. Comparison of effects of transurethral enucleation of prostate and suprapubic prostatectomy in the treatment of massive prostatic hyperplasia. Chinese Journal of Primary Medicine and Pharmacy. 2019; 2467-2470.
Giulianelli R, Gentile BC, Mirabile G, et al. Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison. Prostate Cancer and Prostatic Dis. 2019; 22:110-116. DOI: https://doi.org/10.1038/s41391-018-0080-7
Gratzke C, Schlenker B, Seitz M, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007; 177:1419-1422. DOI: https://doi.org/10.1016/j.juro.2006.11.062
Tubaro A, Carter S, Hind A, et al. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol. 2001; 166:172-176. DOI: https://doi.org/10.1016/S0022-5347(05)66102-2
Serretta V, Morgia G, Fondacaro L, et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002; 60:623-627. DOI: https://doi.org/10.1016/S0090-4295(02)01860-5

How to Cite

Tagreda, I., Heikal, M., Elatreisy, A., Salman, M. F., Soliman, A. M., Koritenah, A. K., Abozied, H., Algammal, M. I., Alrefaey, A. A., Elsalhy, M., Shehab, M., Ali, M. M., Eid, A. G., Abdrabuh, A. M., & Eleweedy, S. (2023). Evaluation of bipolar Transurethral Enucleation and Resection of the Prostate in terms of efficiency and patient satisfaction compared to retropubic open prostatectomy in prostates larger than 80 cc. A prospective randomized study. Archivio Italiano Di Urologia E Andrologia, 95(4). https://doi.org/10.4081/aiua.2023.11629